1,045€
-1,88%
Echtzeit-Aktienkurs XIAOBAI MAIMAI (SPADR)/3
Bid:
Ask:
Echtzeit-Chart der XIAOBAI MAIMAI (SPADR)/3 Aktie
Börsenkurse XIAOBAI MAIMAI (SPADR)/3
| gettex | - | - | - | - | 1,045€ | -1,88% |
| Börse Stuttgart | - | - | - | - | 1,070€ | 0,94% |
| Nasdaq | - | - | - | - | 1,210$ | -6,92% |
Fundamentaldaten der XIAOBAI MAIMAI (SPADR)/3 Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2024 [USD] | 2,41 Mio. | -9,09 Mio. | -9,06 Mio. | -0,19 | - | - | 103,84 |
| 2023 [USD] | 13,18 Mio. | -13,07 Mio. | -1,36 Mio. | -0,06 | - | - | 1,81 |
| 2022 [USD] | 6,31 Mio. | -16,72 Mio. | -16,85 Mio. | -0,85 | - | - | 3,79 |
| 2021 [USD] | 1,75 Mio. | -31,07 Mio. | -37,99 Mio. | -2,33 | - | - | 9,70 |
| 2020 [USD] | 11,44 Mio. | -66,93 Mio. | -71,20 Mio. | -4,38 | - | - | 1,49 |
| 2019 [USD] | 61,33 Mio. | 7,41 Mio. | 5,53 Mio. | 0,34 | - | 3,06 | 0,28 |
| 2018 [USD] | 122,43 Mio. | 76,54 Mio. | 65,48 Mio. | 4,38 | 109,09% | 0,24 | 0,14 |
| 2017 [USD] | 22,92 Mio. | 10,09 Mio. | 8,57 Mio. | 0,60 | - | 1,74 | 0,65 |
| 2016 [USD] | 11,89 Mio. | 4,17 Mio. | 3,54 Mio. | 0,30 | - | 3,48 | 1,26 |
| 2015 [USD] | 4,65 Mio. | -0,31 Mio. | -0,35 Mio. | -0,02 | - | - | 3,22 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der XIAOBAI MAIMAI (SPADR)/3 Aktie
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.